Filing Details
- Accession Number:
- 0001209191-18-047874
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-21 20:02:34
- Reporting Period:
- 2018-08-17
- Accepted Time:
- 2018-08-21 20:02:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1333458 | Joseph Robert Bujarski | 12544 High Bluff Drive, Suite 200 San Diego CA 92130 | Svp, Bus Dev & Gen Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-08-17 | 7,156 | $27.57 | 53,537 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2018-08-17 | 8,798 | $23.41 | 62,335 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2018-08-17 | 17,596 | $15.40 | 79,931 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-08-17 | 38,550 | $70.15 | 41,381 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Options | Disposition | 2018-08-17 | 7,156 | $0.00 | 7,156 | $27.57 |
Common Stock | Non-Qualified Stock Options | Disposition | 2018-08-17 | 8,798 | $0.00 | 8,798 | $23.41 |
Common Stock | Non-Qualified Stock Options | Disposition | 2018-08-17 | 17,596 | $0.00 | 17,596 | $15.40 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2024-02-24 | No | 4 | M | Direct | |
8,798 | 2025-02-05 | No | 4 | M | Direct | |
17,596 | 2026-02-10 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for these transactions was $70.1491 per share, with a range of $69.755 to $70.71. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- 14,130 shares vested on 2/24/2016; 7,155 shares vested on 2/24/2017; 7,156 shares vested on 2/24/2018.
- 17,596 shares vested on 2/5/2017; 8,798 shares vested on 2/5/2018; 8,798 shares will vest on 2/4/2019.
- 17,596 shares vested on 2/10/2018; 8,798 shares will vest on 2/10/2019; 8,798 shares will vest on 2/10/2020.